selegiline hydrochloride

Generic: selegiline hydrochloride

Labeler: rising pharma holdings, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name selegiline hydrochloride
Generic Name selegiline hydrochloride
Labeler rising pharma holdings, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

selegiline hydrochloride 5 mg/1

Manufacturer
Rising Pharma Holdings, Inc.

Identifiers & Regulatory

Product NDC 16571-659
Product ID 16571-659_102210a0-2a43-44c4-aedf-7741b84675ed
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA206803
Listing Expiration 2026-12-31
Marketing Start 2019-04-02

Pharmacologic Class

Classes
monoamine oxidase inhibitor [epc] monoamine oxidase inhibitors [moa] monoamine oxidase type b inhibitor [epc] monoamine oxidase-b inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16571659
Hyphenated Format 16571-659

Supplemental Identifiers

RxCUI
859186
UPC
0316571659067
UNII
6W731X367Q

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name selegiline hydrochloride (source: ndc)
Generic Name selegiline hydrochloride (source: ndc)
Application Number ANDA206803 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 60 CAPSULE in 1 BOTTLE (16571-659-06)
  • 500 CAPSULE in 1 BOTTLE (16571-659-50)
source: ndc

Packages (2)

16571-659-06 60 CAPSULE in 1 BOTTLE (16571-659-06) 16571-659-50 500 CAPSULE in 1 BOTTLE (16571-659-50)

Ingredients (1)

selegiline hydrochloride (5 mg/1)

Linked Drug Pages (1)

Selegiline Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "102210a0-2a43-44c4-aedf-7741b84675ed", "openfda": {"upc": ["0316571659067"], "unii": ["6W731X367Q"], "rxcui": ["859186"], "spl_set_id": ["23c4481f-d150-40c6-addb-b3e454ca914f"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (16571-659-06)", "package_ndc": "16571-659-06", "marketing_start_date": "20190402"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (16571-659-50)", "package_ndc": "16571-659-50", "marketing_start_date": "20190402"}], "brand_name": "Selegiline Hydrochloride", "product_id": "16571-659_102210a0-2a43-44c4-aedf-7741b84675ed", "dosage_form": "CAPSULE", "pharm_class": ["Monoamine Oxidase Inhibitor [EPC]", "Monoamine Oxidase Inhibitors [MoA]", "Monoamine Oxidase Type B Inhibitor [EPC]", "Monoamine Oxidase-B Inhibitors [MoA]"], "product_ndc": "16571-659", "generic_name": "Selegiline Hydrochloride", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Selegiline Hydrochloride", "active_ingredients": [{"name": "SELEGILINE HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA206803", "marketing_category": "ANDA", "marketing_start_date": "20190402", "listing_expiration_date": "20261231"}